Home News Aurobindo Pharma Q3 Results: Net profit up 8% on Europe, ARV growth... News Aurobindo Pharma Q3 Results: Net profit up 8% on Europe, ARV growth despite labour code cost February 9, 2026 FacebookTwitterPinterestWhatsAppLinkedin Shares of Aurobindo Pharma Ltd ended at ₹1,201.25, up by ₹10.10, or 0.85%, on the BSE.Read More RELATED ARTICLESMORE FROM AUTHOR AI AI startup Emergent scales at record speed by letting anyone build apps on their phone News Digital loans in India remains a massive opportunity despite tighter regulations, says investor Mayank Kachhwaha News IRCON Intl Q3 net profit up 16% on higher margins; revenue dips; dividend declared 13,000FansLike9,000FollowersFollowMost PopularAll AllFeaturedAll time popular Fibr AI Raises $5.7 Mn To Strengthen Agentic AI-Powered Martech Stack Uncategorized February 4, 2026 Varaha raises $20M in first tranche of Series B funding led... Uncategorized February 4, 2026 Anthropic, SaaS Panic And The Indian IT Sell-Off: What Really Happened Uncategorized February 5, 2026 5 Reasons Why Ola, Uber, Rapido Drivers Are On National Strike... Uncategorized February 7, 2026 Deeptech-Focussed Golden Sparrow Announces First Close Of $20 Mn Fund II Uncategorized February 4, 2026
